WHWK- Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc. (WHWK) has 6 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. WHWK is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 518.6K | $2.44M | - | |
| Other | 516.0K | $2.42M | - | |
| Other | 55.3K | $260.0K | - | |
| Dir | 38.0K | $178.8K | - | |
| Dir | 38.0K | $178.8K | - |
Activity
Buys and sells only
Transactions
7 filings · page 6
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2017 | Peters Kevin G. | Chief Scientific Officer | Buy | 3,642 | $5.00 | $18,210.00 | +1.1% | |
| Mar 15, 2017 | Gardner Joseph H. | See Remarks | Buy | 99,996 | $5.00 | $499,980.00 | +20.3% | |
| Mar 15, 2017 | Weiss Paul M | Director | Buy | 272,302 | $5.00 | $1,361,510.00 | +20.9% | |
| Mar 15, 2017 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 762,995 | $5.00 | $3,814,975.00 | +20.9% | |
| Mar 15, 2017 | Khuong Chau Quang | Director, 10% Owner | Buy | 762,995 | $5.00 | $3,814,975.00 | +20.9% | |
| Mar 15, 2017 | Castelein Caley | Director | Buy | 400,000 | $5.00 | $2,000,000.00 | +33.0% | |
| Mar 15, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 1,120,000 | $5.00 | $5,600,000.00 | +52.8% |
← PrevPage 6